Publication date: Jul 17, 2024
In response to critical gaps in medical oxygen access, 2 pressure swing adsorption (PSA) oxygen production centers were established using an ecosystem-strengthening strategy in Amhara, Ethiopia, in 2019. A qualitative study was conducted to assess enablers and bottlenecks to oxygen access at the hospital level after installation. A variety of hospital staff (clinicians, biomedical professionals, hospital administrators, and procurement teams) across 13 hospitals procuring oxygen from the plants participated in comprehensive, semistructured focus group discussions. A thematic framework analysis approach was used to identify key themes. A total of 101 individuals participated in 26 focus groups in 2021, 2 years after plants were installed. Primary themes were accessibility of supply, affordability, and hospital readiness. Respondents indicated a substantial increase in their hospital’s ability to access lower-cost oxygen, with many attributing this to the locality of plants and reduced transportation barriers. However, other challenges persisted, and the emergence of COVID-19 1 year after plant installation and a civil conflict exacerbated supply shortages. Investments in equipment, supplies, and training optimized clinical utilization of oxygen and were highlighted as a need for ongoing investment. To achieve maximum impact, investments in large-scale oxygen systems must be accompanied by strategic plans to transport oxygen, reduce costs to hospitals, and provide support to clinical teams through equipment, supply procurement, and clinical training. These findings support comprehensive ecosystem approaches to strengthening oxygen access for sustainable impact.
Concepts | Keywords |
---|---|
Affordability | Adsorption |
Covid | Clinical |
Ethiopian | Ecosystem |
Hospitals | Hospital |
Hospitals | |
Installation | |
Oxygen | |
Plant | |
Plants | |
Pressure | |
Procurement | |
Qualitative | |
Strengthening | |
Supply | |
Swing |
Semantics
Type | Source | Name |
---|---|---|
drug | DRUGBANK | Oxygen |
disease | IDO | production |
drug | DRUGBANK | Etoperidone |
disease | MESH | COVID-19 |